Autogenous Vaccines and Their Role in Animal Health Strategy

Early Registration Ends: July 28

Register Now

Autogenous Vaccines and Their Role
in Animal Health Strategy

September 25-26, 2017
Venue: Het Pand, University of Ghent

Co-organized by IABS-EU and University of Ghent / PROVAXS

 

The purpose of this conference is to start from an overview on the current situation and needs from the perspective of regulators, scientists, manufacturers and the end-user (veterinarians). The main focus will be on food producing animals, including fish. Further, proposals will be presented for a harmonized approach which will lead to a better understanding of the rational for the intended use, better knowledge on the nature of isolates and improved production and quality of the final products. In addition, advanced techniques and methods will be presented and discussed to identify and propagate isolates, to upgrade production and to quickly estimate safety and even efficacy of autogenous vaccines by in vitro methods.

Recommendations will be drafted on how to improve the EU-legislation and communication between the EU-Member States on autogenous vaccines and on ways to increase transparency on quality and safety of the vaccines.

You may now register for this conferenceClick here to register and learn more about the meeting

2nd Human Challenge Trials Conference

Registration Now Open

2nd Human Challenge Trials Conference
Venue: Hilton Hotel, Rockville, Maryland
September 28-30, 2017

 

Our world needs safer, more effective drugs and vaccines to prevent and treat infectious diseases.  Controlled human infections (CHIs) have served as an effective tool to promote this objective. For example, CHIs have led to progress in developing interventions against respiratory pathogens, enteric pathogens, and parasites. The most frequent application is the conduct of human challenge trials (HCTs), which can safely assess the value of novel or improved drugs and vaccines much more rapidly and efficiently than field trials, particularly if efficacy against CHI bridges to the field.  Progress against an infectious threat is greatly hampered when the field lacks a supporting human challenge model, such as is the case for human immunodeficiency virus and Mycobacterium tuberculosis.

Based on the premise that optimal use of CHIs is one of the best, most efficient ways to achieve rapid progress against infectious diseases, IABS is hosting a workshop to review the use of HCTs to promote the development of new drugs and vaccines, the benefits and risks of this approach, the regulatory framework within which HCTs are conducted, and novel CHI applications that would open new translational pathways.  This workshop follows two and a half years after the first such workshop hosted by IABS in Strasbourg, France, September 2014.

You may now register for this conferenceClick here to register and learn more about the meeting

 

Next Generation Sequencing for Adventitious Virus Detection in Biologics

Registration Now Open

Next Generation Sequencing for
Adventitious Virus Detection in Biologics


Venue: USP Pharmacopeia, Rockville, Maryland
October 26-27, 2017

 

The 2017 NGS conference will discuss current perspectives on NGS for adventitious virus detection in biologics with focus on applications for human vaccines and lessons learnt from veterinary vaccines. The meeting will include data presentations and discussions for developing a scientific consensus to draft points for consideration for using NGS for virus detection in selected applications of biologics.  The meeting will bring together representatives from industry, academia, service providers, and regulatory bodies.

You may now register for this conference Click here to register and learn more about the meeting

 

 

4th Statistical and Data Management Approaches for Biotechnology Drug Development

Registration Now Open

4th Statistical and Data Management Approaches
for Biotechnology Drug Development

Venue: USP Pharmacopeia, Rockville, Maryland
October 30 - November 1, 2017

 

This meeting is to bring together regulators, and scientists, or those interested in statistics from academia and industry, who have a background in statistics, to help resolve existing challenges in ensuring the quality of biotechnology medicinal products and to bring high quality medicines to patients. Guidance on how to use statistics for a variety of activities required during biotechnology product development such as method development, improvement and replacement, product comparability, biosimilarity exercises and stability program development will be provided by the speakers and panel members. In addition, the complexity of the types of data and the volume being analysed is ever increasing and how best to manage such data will be discussed. The meeting will bring the right experts together to discuss the issues and through roundtables attempt to reach conclusions that will be valuable globally to public health.

You may now register for this conferenceClick here to register and learn more about the meeting

 

Latest Technologies for the Characterization and Control of Biotechnology Products

Registration Now Open

Latest Technologies for the Characterization
and Control of Biotechnology Products

An IABS, FDA and NIST meeting

Venue: NIST, Gathersburg, Maryland
Green Auditorium
Gathersburg, Maryland
November 6-8, 2017

This meeting is to bring together regulators, and scientists, or those interested in analytics from academia and industry to help resolve existing challenges in ensuring the quality of biotechnology medicinal products and to bring high quality medicines to patients. Guidance on how to use current and novel analytics for a variety of activities required during biotechnology product development such as method development, improvement and replacement, product comparability and process development and execution will be provided by the speakers and panel members. In addition, the complexity of the types of data and the volume being analysed is ever increasing and how best to manage such data will be discussed. The meeting will bring the right experts together to discuss the issues and through roundtables attempt to reach conclusions that will be valuable globally to public health.

 You may now register for this conferenceClick here to register and learn more about the meeting

International Alliance for Biological Standardization


Twitter Feed

#IABS #HUMANCHALLENGETRIALS. #MyronLevine presents #HTCs Perspectives and Current Issues. Register at : https://t.co/f5eiaCgM2T
#IABS#AUTOGENOUSVACCINES and their role in #ANIMALHEALTHSTRATEGY: differences to minor markets/minor use(#MUMS) emergency-regular licensing
Follow IABS_global on Twitter

Contact Info

IABS, Rue de la Vallée, 3
CH-1204 Geneva

Switzerland
+ 41 22 301 10 36
+ 41 22 301 10 37
This email address is being protected from spambots. You need JavaScript enabled to view it.